Form 4: Moderna President Stephen Hoge Reports Stock Transactions

Stephen Hoge, President of Moderna, reports the acquisition and disposal of company stock, including transactions to cover tax obligations related to vesting restricted stock units.

Summary

• On May 31, 2024, Stephen Hoge, President of Moderna, acquired 651 shares of common stock through the conversion of restricted stock units (RSUs).
• On June 3, 2024, Hoge disposed of 339 shares of common stock at a price of $140.7198 per share to cover tax withholding obligations related to the vesting of RSUs.
• Following these transactions, Hoge directly owns 1,472,089 shares of Moderna common stock.
• Hoge also has indirect ownership through Valhalla, LLC (4,116 shares) and a trust for his spouse and children (151,933 shares), but disclaims beneficial ownership of the trust shares except to the extent of his pecuniary interest.
• The reported transactions include the vesting of RSUs, which convert into common stock on a one-for-one basis, with 25% vesting initially on March 1, 2023, and the remainder vesting in equal quarterly installments.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document simply reports stock transactions by an executive, which is a routine regulatory filing. There's no indication of positive or negative implications for the company's performance.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It's typical for executives to sell shares to cover tax obligations when RSUs vest.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their executives.
• The 'sell to cover' transaction for tax obligations is a common method used by executives across various industries, including pharmaceutical companies like Pfizer and Johnson & Johnson.

Stakeholder Impact

• The transactions are unlikely to have a significant impact on stakeholders as they are routine and related to executive compensation and tax obligations.

Key Dates